Amphastar Pharmaceuticals Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 3/6
Amphastar Pharmaceuticals şirketinin toplam hissedar öz sermayesi $713.3M ve toplam borcu $586.6M olup, bu da borç-öz sermaye oranını 82.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $1.5B ve $778.2M dir. Amphastar Pharmaceuticals 'in FAVÖK'ü $232.6M faiz karşılama oranı 10.1 dur. Şirketin $217.8M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler
82.2%
Borç/özkaynak oranı
US$586.58m
Borç
| Faiz karşılama oranı | 10.1x |
| Nakit | US$217.78m |
| Eşitlik | US$713.35m |
| Toplam yükümlülükler | US$778.18m |
| Toplam varlıklar | US$1.49b |
Son finansal sağlık güncellemeleri
Is Amphastar Pharmaceuticals (NASDAQ:AMPH) Using Too Much Debt?
Aug 27
Amphastar Pharmaceuticals (NASDAQ:AMPH) Has A Pretty Healthy Balance Sheet
Mar 27Amphastar Pharmaceuticals (NASDAQ:AMPH) Has A Rock Solid Balance Sheet
Dec 03These 4 Measures Indicate That Amphastar Pharmaceuticals (NASDAQ:AMPH) Is Using Debt Safely
Aug 17We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Manage Its Debt With Ease
May 11Does Amphastar Pharmaceuticals (NASDAQ:AMPH) Have A Healthy Balance Sheet?
Jan 24Recent updates
Amphastar: Objectively Undervalued But For Good Reason (Rating Downgrade)
Oct 25Investors Continue Waiting On Sidelines For Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Sep 15Amphastar: Perplexing Pipeline, Lumpy Revenues - I'm On Sidelines
Sep 12Is Amphastar Pharmaceuticals (NASDAQ:AMPH) Using Too Much Debt?
Aug 27Do Amphastar Pharmaceuticals' (NASDAQ:AMPH) Earnings Warrant Your Attention?
Jul 05Amphastar Pharmaceuticals: Shining Star Soon To Fade With Competitive Pressures Looming
Jul 01Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Subdued P/E Might Signal An Opportunity
May 30Amphastar Pharmaceuticals: Buy When Fear Is Overblown
May 30Reassessing Amphastar Pharmaceuticals
May 15Amphastar Pharmaceuticals (NASDAQ:AMPH) Has A Pretty Healthy Balance Sheet
Mar 27Why Amphastar Pharmaceuticals Is A Strong Buy: Growth, Valuation, And Strategic Acquisitions
Mar 04Here's Why We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Might Deserve Your Attention Today
Jan 04Why Investors Shouldn't Be Surprised By Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) P/E
Dec 20Amphastar Pharmaceuticals (NASDAQ:AMPH) Has A Rock Solid Balance Sheet
Dec 03Amphastar Pharmaceuticals (NASDAQ:AMPH) Ticks All The Boxes When It Comes To Earnings Growth
Sep 18An Intrinsic Calculation For Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Suggests It's 35% Undervalued
Sep 03These 4 Measures Indicate That Amphastar Pharmaceuticals (NASDAQ:AMPH) Is Using Debt Safely
Aug 17Here's Why We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Is Well Worth Watching
Jun 02We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Manage Its Debt With Ease
May 11Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Intrinsic Value Is Potentially 51% Above Its Share Price
Mar 02Is Now The Time To Put Amphastar Pharmaceuticals (NASDAQ:AMPH) On Your Watchlist?
Feb 07Does Amphastar Pharmaceuticals (NASDAQ:AMPH) Have A Healthy Balance Sheet?
Jan 24Here's Why Amphastar Pharmaceuticals (NASDAQ:AMPH) Has Caught The Eye Of Investors
Nov 02Amphastar: A Pharmaceutical Growth Stock
Oct 06Amphastar wins FDA approval for Epinephrine pre-filled syringes
Aug 16Amphastar Pharmaceuticals: Compelling Growth Prospects For H2 2022 And Beyond
Aug 08Do Amphastar Pharmaceuticals' (NASDAQ:AMPH) Earnings Warrant Your Attention?
Jul 24Amphastar generic vasopressin for increasing blood pressure gets FDA approval
Jul 19We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Manage Its Debt With Ease
Jun 10Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: AMPH 'nin kısa vadeli varlıkları ( $482.6M ) kısa vadeli yükümlülüklerini ( $137.0M ) aşıyor.
Uzun Vadeli Yükümlülükler: AMPH 'un kısa vadeli varlıkları ( $482.6M ) uzun vadeli yükümlülüklerini ( $641.2M ) karşılamamaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: AMPH 'nin net borç/öz sermaye oranı ( 51.7% ) yüksek olarak değerlendiriliyor.
Borcun Azaltılması: AMPH şirketinin borç/öz sermaye oranı son 5 yılda 10.6% seviyesinden 82.2% seviyesine yükseldi.
Borç Kapsamı: AMPH 'nin borcu işletme nakit akışı ( 36.2% ) tarafından iyi bir şekilde karşılanmaktadır.
Faiz Kapsamı: AMPH 'in borcuna ilişkin faiz ödemeleri EBIT ( 10.1 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.